OUTCOMES AND EFFECTIVENESS OF PERCUTANEOUS INTERVENTION IN PATIENTS WITH TAKAYASU’S ARTERITIS

Aim. Takayasu’s arteritis (TA) is a chronic inflammatory disease that affects predominantly the aorta. Percutaneous intervention (PI) may be use the TA. In this manuscript, we studied the outcomes (in-hospital and 6 months later) and effectiveness of PI in patients with TA.

Material and methods. The study was performed on 24 consecutive patients (39.3±11.8 (20–61) years; 4 men and 20 women) with TA who were treated with PI, surgical or medical therapy. Nine patients (7 females, 2 male) underwent PI. PI was performed after the erythrocyte sedimentation rate had been normalized in patients with TA.

Results. Although 9 patients received PI with stent for subclavian, carotid, renal and coronary artery, 1 patient received PI with only balloon for brachial artery. One percutaneous transluminal angioplasty and 10 stentings were performed. There was not any complication during interventional procedure. The patients were followed for 6 months. After 6 month, the arteries treated were patent and showed no proliferative lesions in Doppler ultrasound at 8 patients. At a woman patient, left subclavian artery restenosis was determined in Doppler ultrasound and confirmed by angiography. During angiography the stenotic lesion has been successfully treated with balloon angioplasty.

Conclusions. Takayasu’s patients with active systemic disease must receive immunosuppressive therapy before PI. PI was performed after the active period such as during normal erythrocyte sedimentation rate. In these circumstances, PI in patient with TA may be safely and much less traumatic. Also, recurrence of stenosis in patient with TA has been treated successfully by reintervention without significant complications.

1. Brunner J, Feldman BM, Tyrrell PN, et al. Takayasu arteritis in children and adolescents. Rheumatology (Oxford). 2010;49: 1806–14.

2. Ishikawa K, Maetani S. Long-term outcome for 120 Japanese patients with Takayasu’s disease. Clinical and statistical analysis of related prognostic factors. Circulation 1994;90: 1855–60.

3. Kim HJ, Lee CS, Kim JS, et al. Outcomes after endovascular treatment of symptomatic patients with Takayasu’s arteritis. Interv Neuroradiol 2011;17: 252–60.

4. Alvarez-Hernández E. Treatment of large vessel vasculitis. Reumatol Clin 2011;7 Suppl 3: S28–32.

5. Bloch DA, Michel BA, Hunder GG, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. Arthritis Rheum 1990;33: 1068–73.

6. Shelhamer JH, Volkman DJ, Parrillo JE, et al. Takayasu’s arteritis and its therapy. Ann Intern Med 1985;103: 121–6.

7. Hoffmann GS, Leavitt RY, Kerr GS, et al. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 1994;37: 578–82.

8. Giordano JM. Surgical treatment of Takayasu’s arteritis. Int J Cardiol 2000;75 (Suppl 1): S123–8.

9. Sharma BK, Jain S, Bali HK, et al. A follow-up study of balloon angioplasty and de-novo stenting in Takayasu arteritis. Int J Cardiol 2000;75 (Suppl 1): S147–52.

10. Gradden C, McWilliams R, Gould D, et al. Multiple stenting in Takayasu arteritis. J Endovasc Ther 2002;9: 936–40.

11. Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS) Int J Cardiol 1998;66 (Suppl 1): S191–4.

12. Andrew J, Al-Nahhas A, Pennell DJ, et al. Non-invasive imaging in the diagnosis and management of Takayasu’s arteritis. Ann Rheum Dis 2004;63:995–1000.

13. Choe YH, Han BK, Koh EM, Kim DK, Do YS, Lee WR. Takayasu’s arteritis: assessment of disease activity with contrastenhanced MR imaging. Am J Roentgenol 2000;175:505–511.

14. Bali HK, Jain S, Jain A, et al. Stent supported angioplasty in Takayasu arteritis. Int J Cardiol 1998;66 (Suppl 1): S213–7.

15. Lee BB, Laredo J, Neville R, et al. Endovascular management of takayasu arteritis: is it a durable option? Vascular 2009;17: 138–46.

16. Liang P, Hoffman GS. Advances in the medical and surgical treatment of Takayasu arteritis. Curr Opin Rheumatol 2005;17: 16–24.

17. Ozdil E, Parikh DK, Krajcer Z, Angelini P. Stent placement in a patient with Takayasu’s arteritis. Cathet Cardiovasc Diagn 1996;38: 373–6.

18. Tyagi S, Kaul UA, Nair M, Sethi KK, Arora R, Khalilullah M. Balloon angioplasty of the aorta in Takayasu’s arteritis: initial and long-term results. Am Heart J 1992;124: 876–82.

19. Miyamoto S, Wu H, Kubo T, et al. Single stage multiple stenting in Takayasu’s arteritis. Case report. Neurol Med Chir (Tokyo) 2012;52: 219–23.

20. Fritz Angle J, Matsumoto AH, Kevin McGraw J, et al. Percutaneous angioplasty and stenting of left subclavian artery stenosis in patients with left internal mammary-coronary bypass grafts: Clinical experience and long-term follow-up. Vascular and endovascular surgery 2003;37: 89–97.

21. Yadav JS, Wholey MH, Kuntz RE, et al. Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351: 1493–501.

22. Wholey M, Eles G. Clinical experience in cervical carotid artery stent placement. Carotid Neurovasc Int 1998;50: 301–6.

23. Textor SC, Wilcox CS. Renal artery stenosis: A Common, treatable cause of renal failure? Annu Rev Med 2001;52: 421–42.

24. Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998;12: 329–35.